Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Wj Huizinga

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Pharmacogenomics|February 9, 2010
Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritisWouter M Kooloos, Judith Am Wessels, Tahar van der Straaten, et al.
RMD Open|April 19, 2019
Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT studyPaul Emery, Gerd R Burmester, Vivian P Bykerk, et al.
Annals of the Rheumatic Diseases|February 6, 2015
Anticarbamylated protein antibodies can be detected in animal models of arthritis that require active involvement of the adaptive immune systemJeroen N Stoop, Anita Fischer, Silvia Hayer, et al.
RMD Open|August 16, 2019
Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registrySytske Anne Bergstra, Maura C Couto, Nimmisha Govind, et al.
Annals of the Rheumatic Diseases|June 14, 2017
Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritisLeonie E Burgers, Hanna W van Steenbergen, Robin M Ten Brinck, et al.
Annals of the Rheumatic Diseases|April 14, 2021
Prospective study into COVID-19-like symptoms in patients with and without immune-mediated inflammatory diseases or immunomodulating drugsLotte van Ouwerkerk, Andrea E van der Meulen-de Jong, Maarten K Ninaber, et al.
RMD Open|July 29, 2021
White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptomsRory Caitlin Monahan, Francesca Inglese, Huub Middelkoop, et al.
RMD Open|September 8, 2017
Functional limitations in the phase of clinically suspect arthralgia are as serious as in early clinical arthritis; a longitudinal studyRobin M Ten Brinck, Hanna W van Steenbergen, Lukas Mangnus, et al.
Annals of the Rheumatic Diseases|September 1, 2019
On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritisTheresa Kissel, Karin Anna van Schie, Lise Hafkenscheid, et al.
Lupus|October 30, 2021
Dissociation in SLE: A part of lupus fog?Rory C Monahan, Anne Me Blonk, Esther Baptist, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Pharmacogenomics|February 9, 2010
Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritisWouter M Kooloos, Judith Am Wessels, Tahar van der Straaten, et al.
RMD Open|April 19, 2019
Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT studyPaul Emery, Gerd R Burmester, Vivian P Bykerk, et al.
Annals of the Rheumatic Diseases|February 6, 2015
Anticarbamylated protein antibodies can be detected in animal models of arthritis that require active involvement of the adaptive immune systemJeroen N Stoop, Anita Fischer, Silvia Hayer, et al.
RMD Open|August 16, 2019
Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registrySytske Anne Bergstra, Maura C Couto, Nimmisha Govind, et al.
Annals of the Rheumatic Diseases|June 14, 2017
Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritisLeonie E Burgers, Hanna W van Steenbergen, Robin M Ten Brinck, et al.
Annals of the Rheumatic Diseases|April 14, 2021
Prospective study into COVID-19-like symptoms in patients with and without immune-mediated inflammatory diseases or immunomodulating drugsLotte van Ouwerkerk, Andrea E van der Meulen-de Jong, Maarten K Ninaber, et al.
RMD Open|July 29, 2021
White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptomsRory Caitlin Monahan, Francesca Inglese, Huub Middelkoop, et al.
RMD Open|September 8, 2017
Functional limitations in the phase of clinically suspect arthralgia are as serious as in early clinical arthritis; a longitudinal studyRobin M Ten Brinck, Hanna W van Steenbergen, Lukas Mangnus, et al.
Annals of the Rheumatic Diseases|September 1, 2019
On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritisTheresa Kissel, Karin Anna van Schie, Lise Hafkenscheid, et al.
Lupus|October 30, 2021
Dissociation in SLE: A part of lupus fog?Rory C Monahan, Anne Me Blonk, Esther Baptist, et al.
Pageof 5